Loading…
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, Michael A, Sidlow, Robert, Hellmann, Matthew D
Published in The New England journal of medicine (11.01.2018)
Published in The New England journal of medicine (11.01.2018)
Get full text
Journal Article
Loading…
Targeting T Cell Co-receptors for Cancer Therapy
Callahan, Margaret K., Postow, Michael A., Wolchok, Jedd D.
Published in Immunity (Cambridge, Mass.) (17.05.2016)
Published in Immunity (Cambridge, Mass.) (17.05.2016)
Get full text
Journal Article
Loading…
Immune Checkpoint Blockade in Cancer Therapy
Postow, Michael A., Callahan, Margaret K., Wolchok, Jedd D.
Published in Journal of clinical oncology (10.06.2015)
Published in Journal of clinical oncology (10.06.2015)
Get full text
Journal Article
Loading…
Loading…
Loading…
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review
Friedman, Claire F, Proverbs-Singh, Tracy A, Postow, Michael A
Published in JAMA oncology (01.10.2016)
Published in JAMA oncology (01.10.2016)
Get more information
Journal Article
Loading…
Loading…
Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution
Ryder, Mabel, Callahan, Margaret, Postow, Michael A, Wolchok, Jedd, Fagin, James A
Published in Endocrine-related cancer (01.04.2014)
Published in Endocrine-related cancer (01.04.2014)
Get full text
Journal Article
Loading…
Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
Kiess, Ana P., Wolchok, Jedd D., Barker, Christopher A., Postow, Michael A., Tabar, Viviane, Huse, Jason T., Chan, Timothy A., Yamada, Yoshiya, Beal, Kathryn
Published in International journal of radiation oncology, biology, physics (01.06.2015)
Published in International journal of radiation oncology, biology, physics (01.06.2015)
Get full text
Journal Article
Loading…
Loading…
Loading…
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
Rodig, Scott J, Gusenleitner, Daniel, Jackson, Donald G, Gjini, Evisa, Giobbie-Hurder, Anita, Jin, Chelsea, Chang, Han, Lovitch, Scott B, Horak, Christine, Weber, Jeffrey S, Weirather, Jason L, Wolchok, Jedd D, Postow, Michael A, Pavlick, Anna C, Chesney, Jason, Hodi, F Stephen
Published in Science translational medicine (18.07.2018)
Published in Science translational medicine (18.07.2018)
Get more information
Journal Article
Loading…
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma
Del Castillo, Maria, Romero, Fabian A., Argüello, Esther, Kyi, Chrisann, Postow, Michael A., Redelman-Sidi, Gil
Published in Clinical infectious diseases (01.12.2016)
Published in Clinical infectious diseases (01.12.2016)
Get full text
Journal Article
Loading…
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
Hodi, F Stephen, Chesney, Jason, Pavlick, Anna C, Robert, Caroline, Grossmann, Kenneth F, McDermott, David F, Linette, Gerald P, Meyer, Nicolas, Giguere, Jeffrey K, Agarwala, Sanjiv S, Shaheen, Montaser, Ernstoff, Marc S, Minor, David R, Salama, April K, Taylor, Matthew H, Ott, Patrick A, Horak, Christine, Gagnier, Paul, Jiang, Joel, Wolchok, Jedd D, Postow, Michael A
Published in The lancet oncology (01.11.2016)
Published in The lancet oncology (01.11.2016)
Get full text
Journal Article
Loading…
Loading…
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Tawbi, Hussein A, Forsyth, Peter A, Algazi, Alain, Hamid, Omid, Hodi, F. Stephen, Moschos, Stergios J, Khushalani, Nikhil I, Lewis, Karl, Lao, Christopher D, Postow, Michael A, Atkins, Michael B, Ernstoff, Marc S, Reardon, David A, Puzanov, Igor, Kudchadkar, Ragini R, Thomas, Reena P, Tarhini, Ahmad, Pavlick, Anna C, Jiang, Joel, Avila, Alexandre, Demelo, Sheena, Margolin, Kim
Published in The New England journal of medicine (23.08.2018)
Published in The New England journal of medicine (23.08.2018)
Get full text
Journal Article
Loading…
Facts and Hopes in Prediction, Diagnosis, and Treatment of Immune-Related Adverse Events
Smithy, James W., Faleck, David M., Postow, Michael A.
Published in Clinical cancer research (01.04.2022)
Published in Clinical cancer research (01.04.2022)
Get full text
Journal Article
Loading…
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, Alexandra, Makarov, Vladimir, Merghoub, Taha, Yuan, Jianda, Zaretsky, Jesse M, Desrichard, Alexis, Walsh, Logan A, Postow, Michael A, Wong, Phillip, Ho, Teresa S, Hollmann, Travis J, Bruggeman, Cameron, Kannan, Kasthuri, Li, Yanyun, Elipenahli, Ceyhan, Liu, Cailian, Harbison, Christopher T, Wang, Lisu, Ribas, Antoni, Wolchok, Jedd D, Chan, Timothy A
Published in The New England journal of medicine (04.12.2014)
Published in The New England journal of medicine (04.12.2014)
Get full text
Journal Article
Loading…
Loading…
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Robert, Caroline, Ribas, Antoni, Wolchok, Jedd D, Hodi, F Stephen, Hamid, Omid, Kefford, Richard, Weber, Jeffrey S, Joshua, Anthony M, Hwu, Wen-Jen, Gangadhar, Tara C, Patnaik, Amita, Dronca, Roxana, Zarour, Hassane, Joseph, Richard W, Boasberg, Peter, Chmielowski, Bartosz, Mateus, Christine, Postow, Michael A, Gergich, Kevin, Elassaiss-Schaap, Jeroen, Li, Xiaoyun Nicole, Iannone, Robert, Ebbinghaus, Scot W, Kang, S Peter, Daud, Adil
Published in The Lancet (British edition) (20.09.2014)
Published in The Lancet (British edition) (20.09.2014)
Get full text
Journal Article